Tenaya Therapeutics, Inc. (TNYA)
Nasdaq: TNYA · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2021
Who owns Tenaya Therapeutics, Inc.
As filed with the SECHolders of 5% or more
2
The Column Group Opportunity III, LP holds 23.1% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Feb 26, 2026 says.
Directors and officers
11
report now, of 19 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
The Column Group Opportunity III, LP
SCHEDULE 13D/A · filed Feb 26, 2026 · Common Stock, par value $0.0001 per share · 25.4% in Feb 12, 2026
Integrated Core Strategies (US) LLC
SCHEDULE 13G · filed Aug 24, 2026 · Common Stock, par value $0.0001 per share
Woodline Partners LP
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.8% in May 15, 2025
Empery Asset Management, LP
SCHEDULE 13G/A · filed Jul 31, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.96% in May 7, 2025
Casdin Capital, LLC
SCHEDULE 13D/A · filed Mar 7, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
JPMorgan Chase & Co.
SCHEDULE 13G/A · filed Mar 6, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.5% in Feb 10, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 16, 2025 · Common Stock · reported falling below 5%, from 6.7% in Feb 5, 2025
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
What TNYA reports owning in othersstakes of 5% or more, and other ties
Tenaya Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
23sales
0purchases
0sales on a scheduled plan
3people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 30 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Column Group III-A, LP | 10% owner | 8 | $3.5M | 0 | 0 | $0 |
| Tcg Opportunity III Gp, LLC | 10% owner | 4 | $2.4M | 0 | 0 | $0 |
| Ali Faraz | Chief Executive Officer | 9 | $0 | 0 | 0 | $0 |
| Tingley Whittemore | Chief Medical Officer | 9 | $0 | 0 | 0 | $0 |
| Higa Tomohiro | SVP, Finance | 5 | $0 | 0 | 0 | $0 |